Developmental aspects of adenine arabinoside for parenteral therapy of human herpesvirus infections.
D000328:Adult; D000818:Animals; D003586:Cytomegalovirus Infections / Q000188:drug therapy; D004341:Drug Evaluation / Q000379:methods; D004660:Encephalitis / Q000188:drug therapy; D006561:Herpes Simplex / Q000188:drug therapy; D006562:Herpes Zoster / Q000188:drug therapy; D006566:Herpesviridae Infections / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007275:Injections, Intravenous; D051379:Mice; D009705:Nucleosides / Q000008:administration & dosage / Q000627:therapeutic use; D011817:Rabbits; D014740:Vidarabine / Q000008:administration & dosage* / Q000627:therapeutic use
D009705:Nucleosides; D014740:Vidarabine